Utilizing GWAS as a Tool to Define Pathogenic Signalling Pathways Associated with Glomerular Sclerosis & Prioritize New Drug Targets

Time: 11:00 am
day: Day 2 Track 1 AM


  • Performing large-scale and accurate genome-wide association studies to dissect the etiology of FSGS and its subphenotypes
  • Applying this approach to identify novel and specific pathways that are amenable to drug targeting and intervention